DGCI to approve Covaxin for children between 2-18 years after evaluation of data

Drugs Controller General of India will provide approval for Covaxin for children between 2 and18 years only after evaluation of data, official sources said.


Join 2 million subscribers

A curated newsletter that summarizes the important news at the intersection of Global tech, India Tech and AI.

Delivered 8 AM. Daily.
nextbigwhat We would like to show you notifications for the latest news and updates.
Allow Notifications